All Stories

  1. PHD4 Stimulates Tumor Angiogenesis in Osteosarcoma Cells via TGF-α

    Article • Molecular Cancer Research, November 2013, American Association for Cancer Research (AACR)

    Ben Wielockx

  2. Loss of prolyl hydroxylase‐2 in myeloid cells and T‐lymphocytes impairs tumor development

    Article • International Journal of Cancer, August 2013, Wiley

    Ben Wielockx

  3. Loss of Epithelial Hypoxia-Inducible Factor Prolyl Hydroxylase 2 Accelerates Skin Wound Healing in Mice

    Article • Molecular and Cellular Biology, June 2013, ASM Journals

    Ben Wielockx

  4. Erythrocytosis: the HIF pathway in control

    Article • Blood, June 2013, American Society of Hematology

    Ben Wielockx

  5. HIF prolyl hydroxylase 2 (PHD2) is a critical regulator of hematopoietic stem cell maintenance during steady-state and stress

    Article • Blood, May 2013, American Society of Hematology

    Ben Wielockx

  6. HIF-1  is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2 -induced excessive erythropoiesis

    Article • Blood, December 2012, American Society of Hematology

    Ben Wielockx

  7. Interplay between neural-cadherin and vascular endothelial-cadherin in breast cancer progression

    Article • December 2012, Springer Science + Business Media

    Ben Wielockx

  8. Hypoxia‐inducible factors as key regulators of tumor inflammation

    Article • International Journal of Cancer, November 2012, Wiley

    Ben Wielockx

  9. Neuron-Specific Prolyl-4-Hydroxylase Domain 2 Knockout Reduces Brain Injury After Transient Cerebral Ischemia

    Article • Stroke, October 2012, Wolters Kluwer Health

    Ben Wielockx, Professor Hugo H Marti

  10. Hypoxia-Mediated Regulation of Stem Cell Fate

    Article • High Altitude Medicine & Biology, September 2012, Mary Ann Liebert Inc

    Ben Wielockx

  11. HIF prolyl hydroxylase-2 inhibition diminishes tumor growth through matrix metalloproteinase-induced TGFβ activation

    Article • Cancer Biology & Therapy, February 2012, Taylor & Francis

    Ben Wielockx

  12. Overexpression of factor inhibiting HIF‐1 enhances vessel maturation and tumor growth via platelet‐derived growth factor‐C

    Article • International Journal of Cancer, January 2012, Wiley

    Ben Wielockx

  13. Inhibition of HIF Prolyl Hydroxylase-2 Blocks Tumor Growth in Mice through the Antiproliferative Activity of TGFβ

    Article • Cancer Research, April 2011, American Association for Cancer Research (AACR)

    Ben Wielockx

  14. Cardiomyocyte-specific Prolyl-4-hydroxylase Domain 2 Knock Out Protects from Acute Myocardial Ischemic Injury

    Article • Journal of Biological Chemistry, January 2011, American Society for Biochemistry & Molecular Biology (ASBMB)

    Ben Wielockx

  15. Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNγ–based cancer therapy in mice

    Article • Molecular Cancer Therapeutics, September 2007, American Association for Cancer Research (AACR)

    Ben Wielockx

  16. Description and Mapping of the Resistance of DBA/2 Mice to TNF-Induced Lethal Shock

    Article • The Journal of Immunology, April 2007, The American Association of Immunologists

    Ben Wielockx

  17. The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferonγ antitumor therapy

    Article • Cancer Gene Therapy, January 2007, Springer Science + Business Media

    Ben Wielockx

  18. Resistance of Collagenase-2 (Matrix Metalloproteinase-8)-Deficient Mice to TNF-Induced Lethal Hepatitis

    Article • The Journal of Immunology, November 2005, The American Association of Immunologists

    Ben Wielockx

  19. Adenoviral gene transfer of ABIN‐1 protects mice from TNF/galactosamine‐induced acute liver failure and lethality†

    Article • Hepatology, August 2005, Wolters Kluwer Health

    Ben Wielockx, Dr Karim El Bakkouri

  20. Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation?

    Article • Cytokine & Growth Factor Reviews, April 2004, Elsevier

    Ben Wielockx

  21. Serine proteases of the fibrinolysis pathway are not involved in lethal hepatitis and fibrinogen breakdown induced by tumor necrosis factor

    Article • Cytokine, March 2003, Elsevier

    Ben Wielockx

  22. Hyporesponsiveness of SPRET/Ei mice to lethal shock induced by tumor necrosis factor and implications for a TNF-based antitumor therapy

    Article • Proceedings of the National Academy of Sciences, June 2002, Proceedings of the National Academy of Sciences

    Ben Wielockx

  23. HSP70 Protects against TNF-Induced Lethal Inflammatory Shock

    Article • Immunity, May 2002, Elsevier

    Ben Wielockx

  24. Involvement of a serine protease, but not of neutrophil elastase, in tumor necrosis factor-induced lethal hepatitis and induction of platelet-activating factor

    Article • Journal of Hepatology, October 2001, Elsevier

    Ben Wielockx

  25. DETECTION, CHARACTERISATION AND PURIFICATION OF A MURINE LIVER FACTOR CAPABLE OF DESENSITISING TOWARDS THE LETHAL ACTIVITY OF TUMOUR NECROSIS FACTOR

    Article • Cytokine, July 2001, Elsevier

    Ben Wielockx

  26. THE ROLE OF COMPLEMENT ACTIVATION IN TUMOUR NECROSIS FACTOR-INDUCED LETHAL HEPATITIS

    Article • Cytokine, August 1999, Elsevier

    Ben Wielockx

  27. Collecteana Augustiniana

    Article • Ephemerides Theologicae Lovanienses, April 1993, Peeters Publishers

    Ben Wielockx